Patient-Specific Stem Cell Lines Sought
Posted on: Wednesday, 16 May 2007, 12:00 CDT
U.S. scientists have launched a project to develop stem cell lines that genetically match human patients.
University of California-Irvine neurobiologist Hans Keirstead and his team are using a nuclear transfer technique to pursue the goal that will allow scientists to better study conditions ranging from diabetes to Parkinson's disease and provide the basis for potential patient-specific stem cell treatments.
Keirstead uses a technique called somatic cell nuclear transfer in which a patient's DNA is transplanted into a donated unfertilized egg cell in order to generate stem cell lines with the same genetic makeup of the patient. The researchers said such lines have tremendous therapy potential because the human immune system is less likely to attack genetically identical cells.
This technique holds tremendous promise to advance our knowledge of stem cells and their potential to cure disease, said Keirstead, co-director of the university's Gross Stem Cell Research Center. I am excited to embark on this line of research and look forward to the day when patient-specific stem cells are utilized to treat people suffering from debilitating injuries and health conditions.
Source: United Press International
Related Articles
- Neural Stem Cells Offer Potential Treatment For Alzheimer's Disease
- Audio Conference on Consumer-Centric Approaches in Healthcare: How to Drive Patient Satisfaction and Bottom Line Revenues
- Amrubicin Receives FDA Fast Track Designation for the Treatment of Small Cell Lung Cancer After First-Line Chemotherapy
- Cancer Stem Cells Created With Technique Developed at Stanford
- Infinity and MedImmune Initiate Phase 2 Trial of IPI-504 to Assess the Hsp90 Inhibitor's Potential Anti-Tumor Activity in Patients With Advanced Non-Small Cell Lung Cancer
- Threshold Pharmaceuticals Initiates Phase 2 Clinical Trial Evaluating Glufosfamide in Patients With Recurrent, Sensitive Small Cell Lung Cancer
- New Drug Therapy to Combat Graft-Vs.-Host Disease in Stem-Cell Patients Shows Significant Reduction in Deaths
- Advanced Cell Technology Announces Technique to Generate Human Embryonic Stem Cells That Maintains Developmental Potential of Embryo; Approach Published in Nature
- Technique for Bioengineering Cell Sheets Used to Repair Damaged Heart Muscle Is Described in Tissue Engineering
- Cancer Drug May Help Sickle Cell Patients
 |
 |
User Comments (0)
RSS Feeds